Study on frailty in seriously ill adults
Part of Brain & nervous system, Cancer, Heart & circulation, Injuries & trauma, Kidney & urinary, Lungs & breathing clinical trials.
This study looks at why some seriously ill adults become frail. It involves imaging and other tests to help doctors better understand and care for patients with serious conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older, or 18 or older if you are receiving high-dose chemotherapy and a stem cell transplant.
- You have a suspected or diagnosed serious medical condition, such as cancer or another serious illness.
- You have had a CT or MRI scan within the last 45 days, or you are willing to have one before starting a new treatment.
- If you have cancer (other than prostate cancer), the study tests must be done within 1 month before starting a new treatment line.
- If you have prostate cancer and are starting hormonal treatment before radiation, the study tests must be done within 3 months after starting that treatment.
- If you have a serious condition other than cancer, the study tests must be done within 4 days after you are admitted to the hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how frailty (physical weakness and loss of strength) affects older men who have been diagnosed with prostate cancer. Researchers want to understand which men are at higher risk and how this might guide better treatment decisions.
This study uses a simple questionnaire to understand how frailty affects people living with lung cancer. It helps doctors learn more about your overall health and how to better support you.
This trial looks at ways to help “frailty” (low strength and resilience) in people staying in intensive care units. It mainly enrolls adults who expect to be in the ICU for more than 24 hours, and it tries to avoid people whose mobility problems have other causes.
This study evaluates how to better assess and manage frailty (age-related weakness and vulnerability) in older cancer patients aged 70 and up who are starting chemotherapy or other cancer treatments. The goal is to help doctors tailor treatment plans to each patient's individual strength and health status.
This study compares different ways to check frailty (a measure of how well your body handles stress) in women with breast cancer who are 50 or older. The goal is to find which screening tool best predicts health outcomes during treatment.
This trial looks at whether “frailty” (how weak or vulnerable someone is) changes short- and long-term outcomes after surgery. It may help doctors better predict who could benefit from extra support before and after surgery.
Hear when a new Pelvic Fracture trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.